HopeStage
Back to all studies
RecruitingNCT05577585

Ketamine or midazolam for OCD: stress and cognition

About this titleRead the official source — NCT05577585
Medication studyAges 18+Austria
The study in practice

Understand this study

Who could participate?

This study is for people with OCD. Listed age limits: from 18 years. Other eligibility criteria apply.

Listed locations
ViennaSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 1, 2022
Recruitment status
Recruiting
Enrollment listed in the registry
60
Sponsor
Medical University of Vienna
Sponsor type
University
Study type
Drug
Intervention type
Drug, Other
Locations
Austria
Age range
Over 18 Years
Official registry ID
NCT05577585
Official title
Show the full official title

Ketamine Therapy in Obsessive-compulsive Disorder and Its Effects on Neuropsychological Function Under Stress in a Cross-over Trial

Recruitment & locations

Currently recruiting

Vienna

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Medical University of Vienna, a university.

Does this study involve medication?

Yes. The study involves medication, including Ketamine 50 MG/ML Blinded, Midazolam and Ketamine 50 MG/ML Open Label.

Who can participate?

This study is for people with OCD. Listed age limits: from 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies